Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics On-Demand
Antibody Engineering & Therapeutics Anytime, Anywhere
Book Now and Start Streaming Today

Satoshi Tamaki, PhD
CEO and CSO at MOLCURE Inc.
Speaker

Profile

Since 2015, Dr. Tamaki has served as the CSO at MOLCURE, where he has been instrumental in developing next-generation biopharmaceutical exploration technology. This technology integrates artificial intelligence (AI), evolutionary molecular engineering, and laboratory automation. In 2024, he was also appointed as the CEO of MOLCURE, where he continues to shape the company’s vision and growth strategy. Dr. Tamaki earned his Ph.D. in Media and Governance from Keio University.

Agenda Sessions

  • Integration of AI and Wet Lab for the Design of Novel Antibodies

    01:30